Diabetes and Hypertension
Diabetes and Hypertension
Part of NephTimes Diseases and Conditions
Advertisement
Charlotte RobinsonDiabetes and Hypertension | June 7, 2024
A survey found that US physicians would like to find new approaches to lowering patients' blood pressure.
Read More
Victoria SochaDiabetes and Hypertension | May 14, 2024
Could urinary podocyte stress biomarker be a surrogate marker of podocyte injury in diabetic kidney disease (DKD)?
Victoria SochaChronic Kidney Disease | May 9, 2024
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes.
Victoria SochaIgA Nephropathy | May 2, 2024
Researchers studied the effect of intensive blood pressure control on the progression of IgAN. 
Charlotte RobinsonChronic Kidney Disease | May 1, 2024
Researchers explored the association between CSVD and CKD plus the potential role of hypertension in this association.
Charlotte RobinsonDiabetes and Hypertension | May 2, 2024
Researchers examined use of clinical decision support systems to decrease blood pressure in hypertensive patients with CKD.
Freely FilteredDiabetes and Hypertension | April 22, 2024
We've all been guilted into ordering inpatient blood pressure meds. Tim Anderson, MD, asks, "Why?"
Charlotte RobinsonChronic Kidney Disease | April 15, 2024
Kavita Mistry and Marcelle Tuttle will be the American Kidney Fund 2024 Clinical Scientist in Nephrology Fellows.
Charlotte RobinsonDiabetes and Hypertension | April 1, 2024
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Medicare Part D spending on GLP-1 drugs has soared to $5.7 billion, straining Medicare spending.
Charlotte RobinsonDiabetes and Hypertension | March 29, 2024
Current practice guidelines do not address dietary management specific to diabetic kidney disease (DKD).
Charlotte RobinsonDiabetes and Hypertension | March 8, 2024
AstraZeneca has removed tozorakimab from its phase 2 pipeline for diabetic kidney disease.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Patients with diabetic kidney disease face increased risk of end-stage kidney disease and dialysis.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Albuminuria, hypertension, declining kidney function, and an increase in cardiovascular risk are all hallmarks of DKD.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Strategies for the accurate evaluation of the risk of fragility fractures in elderly patients in the early stages of DKD.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Compared with DPP4 inhibitors, SGLT2 inhibitors were associated with a lower risk for the kidney-specific outcome.
Victoria SochaDiabetes and Hypertension | February 5, 2024
In patients with type 2 diabetes mellitus, identifying nondiabetic kidney disease is crucial in delaying progression of CKD.
Victoria SochaChronic Kidney Disease | February 5, 2024
Development and validation of a model to predict future trajectories in eGFR in adults with type 2 diabetes and CKD.
Victoria SochaChronic Kidney Disease | February 5, 2024
A 2004 landmark study demonstrated an association between chronic kidney disease and an increased risk of CV events.
Victoria SochaDiabetes and Hypertension | February 5, 2024
Early diagnosis of CKD and active management can slow progression and improve outcomes.
Advertisement
Advertisement
Advertisement
Latest News

June 21, 2024